Möchten Sie immer auf dem neuesten Stand bleiben?

Net Income improves by $5.2M and Adjusted EBITDA rises by $6.4M over prior year Gross Margin reaches 57.4%, an expansion of 540 basis points versus prior year Strong balance sheet with approximately...

New York, USA, June 08, 2026 (GLOBE NEWSWIRE) -- Key Highlights XOVR long-term shareholders have already benefited from approximately $50 million in unrealized appreciation reflected in the Fund's...

COPENHAGEN, Denmark, June 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for...

Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle

ING to appoint Andrea Cesaroni as chief risk officer ING announced today that Andrea Cesaroni will be appointed chief risk officer of ING. Andrea has been the head of Integrated Risk at ING since...

CIP sells minority stakes in its 500MW construction-stage Devilla BESS project to Scottish National Investment Bank and NLF, retaining majority ownership

Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026 Halle (Saale) / Munich, Germany, June 8, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7)...

Strategic collaboration combines Nurix’s leadership in targeted protein degradation with Roche’s portfolio of B-cell targeted therapies and global clinical and commercialization footprint Robust...

WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace First Quantum Security Service to Launch Within SEALCOIN’s Dedicated...

Sarclisa SC approved in EU: first anticancer via on-body injector CirCLIQ®. Flexible home/clinic administration for multiple myeloma patients.